#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0003] Usually, for detecting DNA sequences in pathogen diagnostics, amplification techniques are used, for example PCR or RT-PCR, in order to increase the quantity of pathogen-specific DNA contained in the sample.
1-1	0-1	[	_	_	
1-2	1-5	0003	_	_	
1-3	5-6	]	_	_	
1-4	7-14	Usually	_	_	
1-5	14-15	,	_	_	
1-6	16-19	for	_	_	
1-7	20-29	detecting	_	_	
1-8	30-33	DNA	_	_	
1-9	34-43	sequences	_	_	
1-10	44-46	in	_	_	
1-11	47-55	pathogen	_	_	
1-12	56-67	diagnostics	_	_	
1-13	67-68	,	_	_	
1-14	69-82	amplification	_	_	
1-15	83-93	techniques	_	_	
1-16	94-97	are	_	_	
1-17	98-102	used	_	_	
1-18	102-103	,	_	_	
1-19	104-107	for	_	_	
1-20	108-115	example	_	_	
1-21	116-119	PCR	_	_	
1-22	120-122	or	_	_	
1-23	123-129	RT-PCR	_	_	
1-24	129-130	,	_	_	
1-25	131-133	in	_	_	
1-26	134-139	order	_	_	
1-27	140-142	to	_	_	
1-28	143-151	increase	_	_	
1-29	152-155	the	_	_	
1-30	156-164	quantity	_	_	
1-31	165-167	of	_	_	
1-32	168-185	pathogen-specific	_	_	
1-33	186-189	DNA	_	_	
1-34	190-199	contained	_	_	
1-35	200-202	in	_	_	
1-36	203-206	the	_	_	
1-37	207-213	sample	_	_	
1-38	213-214	.	_	_	

#Text=In a first step, usually a DNA purification is carried out starting from the respective patient sample (for example blood, serum, tissue, or the like).
2-1	215-217	In	_	_	
2-2	218-219	a	_	_	
2-3	220-225	first	_	_	
2-4	226-230	step	_	_	
2-5	230-231	,	_	_	
2-6	232-239	usually	_	_	
2-7	240-241	a	_	_	
2-8	242-245	DNA	_	_	
2-9	246-258	purification	_	_	
2-10	259-261	is	_	_	
2-11	262-269	carried	_	_	
2-12	270-273	out	_	_	
2-13	274-282	starting	_	_	
2-14	283-287	from	_	_	
2-15	288-291	the	_	_	
2-16	292-302	respective	_	_	
2-17	303-310	patient	_	_	
2-18	311-317	sample	_	_	
2-19	318-319	(	_	_	
2-20	319-322	for	_	_	
2-21	323-330	example	_	_	
2-22	331-336	blood	_	_	
2-23	336-337	,	_	_	
2-24	338-343	serum	_	_	
2-25	343-344	,	_	_	
2-26	345-351	tissue	_	_	
2-27	351-352	,	_	_	
2-28	353-355	or	_	_	
2-29	356-359	the	_	_	
2-30	360-364	like	_	_	
2-31	364-365	)	_	_	
2-32	365-366	.	_	_	

#Text=Depending on the nature of pathogen to be detected, the purified DNA can be obtained from bacterial cells or from cells of the affected tissue of the patient in question (e.g. in the case of infection with viruses whose DNA integrates into the genomic DNA of the infected host cells).
3-1	367-376	Depending	_	_	
3-2	377-379	on	_	_	
3-3	380-383	the	_	_	
3-4	384-390	nature	_	_	
3-5	391-393	of	_	_	
3-6	394-402	pathogen	_	_	
3-7	403-405	to	_	_	
3-8	406-408	be	_	_	
3-9	409-417	detected	_	_	
3-10	417-418	,	_	_	
3-11	419-422	the	_	_	
3-12	423-431	purified	_	_	
3-13	432-435	DNA	_	_	
3-14	436-439	can	_	_	
3-15	440-442	be	_	_	
3-16	443-451	obtained	_	_	
3-17	452-456	from	_	_	
3-18	457-466	bacterial	_	_	
3-19	467-472	cells	_	_	
3-20	473-475	or	_	_	
3-21	476-480	from	_	_	
3-22	481-486	cells	_	_	
3-23	487-489	of	_	_	
3-24	490-493	the	_	_	
3-25	494-502	affected	_	_	
3-26	503-509	tissue	_	_	
3-27	510-512	of	_	_	
3-28	513-516	the	_	_	
3-29	517-524	patient	_	_	
3-30	525-527	in	_	_	
3-31	528-536	question	_	_	
3-32	537-538	(	_	_	
3-33	538-541	e.g	_	_	
3-34	541-542	.	_	_	
3-35	543-545	in	_	_	
3-36	546-549	the	_	_	
3-37	550-554	case	_	_	
3-38	555-557	of	_	_	
3-39	558-567	infection	_	_	
3-40	568-572	with	_	_	
3-41	573-580	viruses	_	_	
3-42	581-586	whose	_	_	
3-43	587-590	DNA	_	_	
3-44	591-601	integrates	_	_	
3-45	602-606	into	_	_	
3-46	607-610	the	_	_	
3-47	611-618	genomic	_	_	
3-48	619-622	DNA	_	_	
3-49	623-625	of	_	_	
3-50	626-629	the	_	_	
3-51	630-638	infected	_	_	
3-52	639-643	host	_	_	
3-53	644-649	cells	_	_	
3-54	649-650	)	_	_	
3-55	650-651	.	_	_	

#Text=The purified DNA can then be used in the respective amplification method, using primers that are specific with respect to their sequence to the pathogen to be detected.
#Text=[0004] Another possibility for the detection of pathogen-specific DNA sequences is offered by DNA hybridization methods, in which the presence of a defined DNA sequence is detected by hybridization with labeled probes.
4-1	652-655	The	_	_	
4-2	656-664	purified	_	_	
4-3	665-668	DNA	_	_	
4-4	669-672	can	_	_	
4-5	673-677	then	_	_	
4-6	678-680	be	_	_	
4-7	681-685	used	_	_	
4-8	686-688	in	_	_	
4-9	689-692	the	_	_	
4-10	693-703	respective	_	_	
4-11	704-717	amplification	_	_	
4-12	718-724	method	_	_	
4-13	724-725	,	_	_	
4-14	726-731	using	_	_	
4-15	732-739	primers	_	_	
4-16	740-744	that	_	_	
4-17	745-748	are	_	_	
4-18	749-757	specific	_	_	
4-19	758-762	with	_	_	
4-20	763-770	respect	_	_	
4-21	771-773	to	_	_	
4-22	774-779	their	_	_	
4-23	780-788	sequence	_	_	
4-24	789-791	to	_	_	
4-25	792-795	the	_	_	
4-26	796-804	pathogen	_	_	
4-27	805-807	to	_	_	
4-28	808-810	be	_	_	
4-29	811-819	detected	_	_	
4-30	819-820	.	_	_	
4-31	821-822	[	*[1]	6-2[2_1]	
4-32	822-826	0004	*[1]	_	
4-33	826-827	]	*[1]	_	
4-34	828-835	Another	*[1]	_	
4-35	836-847	possibility	*[1]	_	
4-36	848-851	for	*[1]	_	
4-37	852-855	the	*[1]	_	
4-38	856-865	detection	*[1]	_	
4-39	866-868	of	*[1]	_	
4-40	869-886	pathogen-specific	*[1]	_	
4-41	887-890	DNA	*[1]	_	
4-42	891-900	sequences	*[1]	_	
4-43	901-903	is	*[1]	_	
4-44	904-911	offered	*[1]	_	
4-45	912-914	by	*[1]	_	
4-46	915-918	DNA	*[1]	_	
4-47	919-932	hybridization	*[1]	_	
4-48	933-940	methods	*[1]	_	
4-49	940-941	,	*[1]	_	
4-50	942-944	in	*[1]	_	
4-51	945-950	which	*[1]	_	
4-52	951-954	the	*[1]	_	
4-53	955-963	presence	*[1]	_	
4-54	964-966	of	*[1]	_	
4-55	967-968	a	*[1]	_	
4-56	969-976	defined	*[1]	_	
4-57	977-980	DNA	*[1]	_	
4-58	981-989	sequence	*[1]	_	
4-59	990-992	is	*[1]	_	
4-60	993-1001	detected	*[1]	_	
4-61	1002-1004	by	*[1]	_	
4-62	1005-1018	hybridization	*[1]	_	
4-63	1019-1023	with	*[1]	_	
4-64	1024-1031	labeled	*[1]	_	
4-65	1032-1038	probes	*[1]	_	
4-66	1038-1039	.	*[1]	_	

#Text=A classical way of carrying out DNA hybridization methods is Southern blotting.
5-1	1040-1041	A	_	_	
5-2	1042-1051	classical	_	_	
5-3	1052-1055	way	_	_	
5-4	1056-1058	of	_	_	
5-5	1059-1067	carrying	_	_	
5-6	1068-1071	out	_	_	
5-7	1072-1075	DNA	_	_	
5-8	1076-1089	hybridization	_	_	
5-9	1090-1097	methods	_	_	
5-10	1098-1100	is	_	_	
5-11	1101-1109	Southern	_	_	
5-12	1110-1118	blotting	_	_	
5-13	1118-1119	.	_	_	

#Text=In this method the DNA isolated from the cells or tissues is, after fragmentation with restriction endonucleases, separated by gel electrophoresis, transferred to a membrane (e.g. a nitro-cellulose or nylon membrane), immobilized and hybridized to an appropriately labeled oligonucleotide probe.
6-1	1120-1122	In	_	_	
6-2	1123-1127	this	*[2]	_	
6-3	1128-1134	method	*[2]	_	
6-4	1135-1138	the	_	_	
6-5	1139-1142	DNA	_	_	
6-6	1143-1151	isolated	_	_	
6-7	1152-1156	from	_	_	
6-8	1157-1160	the	_	_	
6-9	1161-1166	cells	_	_	
6-10	1167-1169	or	_	_	
6-11	1170-1177	tissues	_	_	
6-12	1178-1180	is	_	_	
6-13	1180-1181	,	_	_	
6-14	1182-1187	after	_	_	
6-15	1188-1201	fragmentation	_	_	
6-16	1202-1206	with	_	_	
6-17	1207-1218	restriction	_	_	
6-18	1219-1232	endonucleases	_	_	
6-19	1232-1233	,	_	_	
6-20	1234-1243	separated	_	_	
6-21	1244-1246	by	_	_	
6-22	1247-1250	gel	_	_	
6-23	1251-1266	electrophoresis	_	_	
6-24	1266-1267	,	_	_	
6-25	1268-1279	transferred	_	_	
6-26	1280-1282	to	_	_	
6-27	1283-1284	a	_	_	
6-28	1285-1293	membrane	_	_	
6-29	1294-1295	(	_	_	
6-30	1295-1298	e.g	_	_	
6-31	1298-1299	.	_	_	
6-32	1300-1301	a	_	_	
6-33	1302-1317	nitro-cellulose	_	_	
6-34	1318-1320	or	_	_	
6-35	1321-1326	nylon	_	_	
6-36	1327-1335	membrane	_	_	
6-37	1335-1336	)	_	_	
6-38	1336-1337	,	_	_	
6-39	1338-1349	immobilized	_	_	
6-40	1350-1353	and	_	_	
6-41	1354-1364	hybridized	_	_	
6-42	1365-1367	to	_	_	
6-43	1368-1370	an	_	_	
6-44	1371-1384	appropriately	_	_	
6-45	1385-1392	labeled	_	_	
6-46	1393-1408	oligonucleotide	_	_	
6-47	1409-1414	probe	_	_	
6-48	1414-1415	.	_	_	

#Text=As an alter-native, the isolated DNA can be put on a membrane directly and then hybridized (dot blot).
7-1	1416-1418	As	_	_	
7-2	1419-1421	an	_	_	
7-3	1422-1434	alter-native	_	_	
7-4	1434-1435	,	_	_	
7-5	1436-1439	the	_	_	
7-6	1440-1448	isolated	_	_	
7-7	1449-1452	DNA	_	_	
7-8	1453-1456	can	_	_	
7-9	1457-1459	be	_	_	
7-10	1460-1463	put	_	_	
7-11	1464-1466	on	_	_	
7-12	1467-1468	a	_	_	
7-13	1469-1477	membrane	_	_	
7-14	1478-1486	directly	_	_	
7-15	1487-1490	and	_	_	
7-16	1491-1495	then	_	_	
7-17	1496-1506	hybridized	_	_	
7-18	1507-1508	(	_	_	
7-19	1508-1511	dot	_	_	
7-20	1512-1516	blot	_	_	
7-21	1516-1517	)	_	_	
7-22	1517-1518	.	_	_	

#Text=Southern blotting is often employed for investigating gene rearrangements.
#Text=[0005] In addition to Southern blotting, in situ hybridization has also become established in pathogen diagnostics.
8-1	1519-1527	Southern	_	_	
8-2	1528-1536	blotting	_	_	
8-3	1537-1539	is	_	_	
8-4	1540-1545	often	_	_	
8-5	1546-1554	employed	_	_	
8-6	1555-1558	for	_	_	
8-7	1559-1572	investigating	_	_	
8-8	1573-1577	gene	_	_	
8-9	1578-1592	rearrangements	_	_	
8-10	1592-1593	.	_	_	
8-11	1594-1595	[	_	_	
8-12	1595-1599	0005	_	_	
8-13	1599-1600	]	_	_	
8-14	1601-1603	In	_	_	
8-15	1604-1612	addition	_	_	
8-16	1613-1615	to	_	_	
8-17	1616-1624	Southern	_	_	
8-18	1625-1633	blotting	_	_	
8-19	1633-1634	,	_	_	
8-20	1635-1637	in	_	_	
8-21	1638-1642	situ	_	_	
8-22	1643-1656	hybridization	_	_	
8-23	1657-1660	has	_	_	
8-24	1661-1665	also	_	_	
8-25	1666-1672	become	_	_	
8-26	1673-1684	established	_	_	
8-27	1685-1687	in	_	_	
8-28	1688-1696	pathogen	_	_	
8-29	1697-1708	diagnostics	_	_	
8-30	1708-1709	.	_	_	

#Text=In situ hybridization means the direct detection of nucleic acid sequences in sections and cell preparations using suitable probes.
9-1	1710-1712	In	_	_	
9-2	1713-1717	situ	_	_	
9-3	1718-1731	hybridization	_	_	
9-4	1732-1737	means	_	_	
9-5	1738-1741	the	_	_	
9-6	1742-1748	direct	_	_	
9-7	1749-1758	detection	_	_	
9-8	1759-1761	of	_	_	
9-9	1762-1769	nucleic	_	_	
9-10	1770-1774	acid	_	_	
9-11	1775-1784	sequences	_	_	
9-12	1785-1787	in	_	_	
9-13	1788-1796	sections	_	_	
9-14	1797-1800	and	_	_	
9-15	1801-1805	cell	_	_	
9-16	1806-1818	preparations	_	_	
9-17	1819-1824	using	_	_	
9-18	1825-1833	suitable	_	_	
9-19	1834-1840	probes	_	_	
9-20	1840-1841	.	_	_	

#Text=This method is already used in many laboratories for detecting viral DNA (cytomegalovirus, herpesviruses, etc.) in tissue sections and in cells.
10-1	1842-1846	This	_	_	
10-2	1847-1853	method	_	_	
10-3	1854-1856	is	_	_	
10-4	1857-1864	already	_	_	
10-5	1865-1869	used	_	_	
10-6	1870-1872	in	_	_	
10-7	1873-1877	many	_	_	
10-8	1878-1890	laboratories	_	_	
10-9	1891-1894	for	_	_	
10-10	1895-1904	detecting	_	_	
10-11	1905-1910	viral	_	_	
10-12	1911-1914	DNA	_	_	
10-13	1915-1916	(	_	_	
10-14	1916-1931	cytomegalovirus	_	_	
10-15	1931-1932	,	_	_	
10-16	1933-1946	herpesviruses	_	_	
10-17	1946-1947	,	_	_	
10-18	1948-1951	etc	_	_	
10-19	1951-1952	.	_	_	
10-20	1952-1953	)	_	_	
10-21	1954-1956	in	_	_	
10-22	1957-1963	tissue	_	_	
10-23	1964-1972	sections	_	_	
10-24	1973-1976	and	_	_	
10-25	1977-1979	in	_	_	
10-26	1980-1985	cells	_	_	
10-27	1985-1986	.	_	_	

#Text=In addition, the method can be used for the analysis of structural chromosomal changes.
#Text=[0006] The probes used in DNA hybridization methods can be labeled in various ways, for example with fluorescent molecules or with groups that can be detected immunologically from reaction with an antibody.
11-1	1987-1989	In	_	_	
11-2	1990-1998	addition	_	_	
11-3	1998-1999	,	_	_	
11-4	2000-2003	the	_	_	
11-5	2004-2010	method	_	_	
11-6	2011-2014	can	_	_	
11-7	2015-2017	be	_	_	
11-8	2018-2022	used	_	_	
11-9	2023-2026	for	_	_	
11-10	2027-2030	the	_	_	
11-11	2031-2039	analysis	_	_	
11-12	2040-2042	of	_	_	
11-13	2043-2053	structural	_	_	
11-14	2054-2065	chromosomal	_	_	
11-15	2066-2073	changes	_	_	
11-16	2073-2074	.	_	_	
11-17	2075-2076	[	_	_	
11-18	2076-2080	0006	_	_	
11-19	2080-2081	]	_	_	
11-20	2082-2085	The	_	_	
11-21	2086-2092	probes	_	_	
11-22	2093-2097	used	_	_	
11-23	2098-2100	in	_	_	
11-24	2101-2104	DNA	_	_	
11-25	2105-2118	hybridization	_	_	
11-26	2119-2126	methods	_	_	
11-27	2127-2130	can	_	_	
11-28	2131-2133	be	_	_	
11-29	2134-2141	labeled	_	_	
11-30	2142-2144	in	_	_	
11-31	2145-2152	various	_	_	
11-32	2153-2157	ways	_	_	
11-33	2157-2158	,	_	_	
11-34	2159-2162	for	_	_	
11-35	2163-2170	example	_	_	
11-36	2171-2175	with	_	_	
11-37	2176-2187	fluorescent	_	_	
11-38	2188-2197	molecules	_	_	
11-39	2198-2200	or	_	_	
11-40	2201-2205	with	_	_	
11-41	2206-2212	groups	_	_	
11-42	2213-2217	that	_	_	
11-43	2218-2221	can	_	_	
11-44	2222-2224	be	_	_	
11-45	2225-2233	detected	_	_	
11-46	2234-2249	immunologically	_	_	
11-47	2250-2254	from	_	_	
11-48	2255-2263	reaction	_	_	
11-49	2264-2268	with	_	_	
11-50	2269-2271	an	_	_	
11-51	2272-2280	antibody	_	_	
11-52	2280-2281	.	_	_	

#Text=Hybridization methods normally also require purification of the DNA to be investigated.
#Text=[0007] The methods for DNA detection described up to now in the prior art have the disadvantage that relatively expensive equipment, for example PCR thermocyclers, fluorescence microscopes or similar are necessary for obtaining information regarding the presence of the DNA sequence to be detected.
12-1	2282-2295	Hybridization	_	_	
12-2	2296-2303	methods	_	_	
12-3	2304-2312	normally	_	_	
12-4	2313-2317	also	_	_	
12-5	2318-2325	require	_	_	
12-6	2326-2338	purification	_	_	
12-7	2339-2341	of	_	_	
12-8	2342-2345	the	_	_	
12-9	2346-2349	DNA	_	_	
12-10	2350-2352	to	_	_	
12-11	2353-2355	be	_	_	
12-12	2356-2368	investigated	_	_	
12-13	2368-2369	.	_	_	
12-14	2370-2371	[	_	_	
12-15	2371-2375	0007	_	_	
12-16	2375-2376	]	_	_	
12-17	2377-2380	The	_	_	
12-18	2381-2388	methods	_	_	
12-19	2389-2392	for	_	_	
12-20	2393-2396	DNA	_	_	
12-21	2397-2406	detection	_	_	
12-22	2407-2416	described	_	_	
12-23	2417-2419	up	_	_	
12-24	2420-2422	to	_	_	
12-25	2423-2426	now	_	_	
12-26	2427-2429	in	_	_	
12-27	2430-2433	the	_	_	
12-28	2434-2439	prior	_	_	
12-29	2440-2443	art	_	_	
12-30	2444-2448	have	_	_	
12-31	2449-2452	the	_	_	
12-32	2453-2465	disadvantage	_	_	
12-33	2466-2470	that	_	_	
12-34	2471-2481	relatively	_	_	
12-35	2482-2491	expensive	_	_	
12-36	2492-2501	equipment	_	_	
12-37	2501-2502	,	_	_	
12-38	2503-2506	for	_	_	
12-39	2507-2514	example	_	_	
12-40	2515-2518	PCR	_	_	
12-41	2519-2532	thermocyclers	_	_	
12-42	2532-2533	,	_	_	
12-43	2534-2546	fluorescence	_	_	
12-44	2547-2558	microscopes	_	_	
12-45	2559-2561	or	_	_	
12-46	2562-2569	similar	_	_	
12-47	2570-2573	are	_	_	
12-48	2574-2583	necessary	_	_	
12-49	2584-2587	for	_	_	
12-50	2588-2597	obtaining	_	_	
12-51	2598-2609	information	_	_	
12-52	2610-2619	regarding	_	_	
12-53	2620-2623	the	_	_	
12-54	2624-2632	presence	_	_	
12-55	2633-2635	of	_	_	
12-56	2636-2639	the	_	_	
12-57	2640-2643	DNA	_	_	
12-58	2644-2652	sequence	_	_	
12-59	2653-2655	to	_	_	
12-60	2656-2658	be	_	_	
12-61	2659-2667	detected	_	_	
12-62	2667-2668	.	_	_	

#Text=Furthermore, these methods only provide an evaluation after a considerable delay, which arises from the downstream processes.
13-1	2669-2680	Furthermore	_	_	
13-2	2680-2681	,	_	_	
13-3	2682-2687	these	_	_	
13-4	2688-2695	methods	_	_	
13-5	2696-2700	only	_	_	
13-6	2701-2708	provide	_	_	
13-7	2709-2711	an	_	_	
13-8	2712-2722	evaluation	_	_	
13-9	2723-2728	after	_	_	
13-10	2729-2730	a	_	_	
13-11	2731-2743	considerable	_	_	
13-12	2744-2749	delay	_	_	
13-13	2749-2750	,	_	_	
13-14	2751-2756	which	_	_	
13-15	2757-2763	arises	_	_	
13-16	2764-2768	from	_	_	
13-17	2769-2772	the	_	_	
13-18	2773-2783	downstream	_	_	
13-19	2784-2793	processes	_	_	
13-20	2793-2794	.	_	_	

#Text=Moreover, as a rule the methods first require purification of the DNA used, which involves further costs and expenditure of time.
14-1	2795-2803	Moreover	_	_	
14-2	2803-2804	,	_	_	
14-3	2805-2807	as	_	_	
14-4	2808-2809	a	_	_	
14-5	2810-2814	rule	_	_	
14-6	2815-2818	the	_	_	
14-7	2819-2826	methods	_	_	
14-8	2827-2832	first	_	_	
14-9	2833-2840	require	_	_	
14-10	2841-2853	purification	_	_	
14-11	2854-2856	of	_	_	
14-12	2857-2860	the	_	_	
14-13	2861-2864	DNA	_	_	
14-14	2865-2869	used	_	_	
14-15	2869-2870	,	_	_	
14-16	2871-2876	which	_	_	
14-17	2877-2885	involves	_	_	
14-18	2886-2893	further	_	_	
14-19	2894-2899	costs	_	_	
14-20	2900-2903	and	_	_	
14-21	2904-2915	expenditure	_	_	
14-22	2916-2918	of	_	_	
14-23	2919-2923	time	_	_	
14-24	2923-2924	.	_	_	
